 |
Video: What is a Stock Split?
|
 |
Synthetic Biologics is a clinical-stage company developing therapeutics designed to prevent and treat gastrointestinal (GI) diseases. Co.'s main clinical development candidates are: SYN-004 (ribaxamase) which is designed to degrade certain commonly used intravenous beta-lactam antibiotics within the GI tract to prevent microbiome damage, Clostridioides difficile infection, overgrowth of pathogenic organisms, the emergence of antimicrobial resistance and acute graft-versus-host-disease in allogeneic hematopoietic cell transplant recipients; and SYN-020, a recombinant oral formulation of the enzyme intestinal alkaline phosphatase intended to treat both local GI and systemic diseases. According to our SYN split history records, SYN has had 2 splits. | |
 |

SYN (SYN) has 2 splits in our SYN split history database. The first split for SYN took place on August 13, 2018. This was a 1 for 35 reverse split, meaning for each 35 shares of SYN owned pre-split, the shareholder now owned 1 share. For example, a 1000 share position pre-split, became a 28.5714285714286 share position following the split. SYN's second split took place on July 25, 2022. This was a 1 for 10 reverse split, meaning for each 10 shares of SYN owned pre-split, the shareholder now owned 1 share. For example, a 28.5714285714286 share position pre-split, became a 2.85714285714286 share position following the split.
When a company such as SYN conducts a reverse share split, it is usually because shares have fallen to a lower per-share pricepoint than the company would like. This can be important because, for example, certain types of mutual funds might have a limit governing which stocks they may buy, based upon per-share price. The $5 and $10 pricepoints tend to be important in this regard. Stock exchanges also tend to look at per-share price, setting a lower limit for listing eligibility. So when a company does a reverse split, it is looking mathematically at the market capitalization before and after the reverse split takes place, and concluding that if the market capitilization remains stable, the reduced share count should result in a higher price per share.
Looking at the SYN split history from start to finish, an original position size of 1000 shares would have turned into 2.85714285714286 today. Below, we examine the compound annual growth rate — CAGR for short — of an investment into SYN shares, starting with a $10,000 purchase of SYN, presented on a split-history-adjusted basis factoring in the complete SYN split history.

Growth of $10,000.00
Without Dividends Reinvested
|
Start date: |
02/12/2015 |
|
End date: |
10/12/2022 |
|
Start price/share: |
$682.50 |
|
End price/share: |
$1.02 |
|
Dividends collected/share: |
$0.00 |
|
Total return: |
-99.85% |
|
Average Annual Total Return: |
-57.20% |
|
Starting investment: |
$10,000.00 |
|
Ending investment: |
$14.95 |
|
Years: |
7.67 |
|
|
 |
Date |
Ratio |
08/13/2018 | 1 for 35 | 07/25/2022 | 1 for 10 |
|
 |